Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 82,056 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky sold 82,056 shares of Tempus AI stock in a transaction that occurred on Friday, January 31st. The shares were sold at an average price of $58.21, for a total transaction of $4,776,479.76. Following the sale, the chief executive officer now directly owns 5,532,987 shares of the company’s stock, valued at $322,075,173.27. This represents a 1.46 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Tempus AI Stock Up 0.3 %

Shares of NASDAQ:TEM opened at $57.39 on Friday. The business’s 50-day moving average is $44.18 and its 200 day moving average is $48.18. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49.

Institutional Investors Weigh In On Tempus AI

Large investors have recently modified their holdings of the business. First Horizon Advisors Inc. purchased a new stake in Tempus AI during the 3rd quarter worth approximately $30,000. FNY Investment Advisers LLC purchased a new stake in shares of Tempus AI during the fourth quarter valued at $67,000. Vestor Capital LLC acquired a new position in shares of Tempus AI in the 3rd quarter valued at $153,000. Stifel Financial Corp purchased a new position in Tempus AI in the 3rd quarter worth $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new position in Tempus AI in the 3rd quarter worth $258,000. Hedge funds and other institutional investors own 24.22% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on TEM. Wolfe Research initiated coverage on Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price objective on the stock. Stifel Nicolaus lowered Tempus AI from a “buy” rating to a “hold” rating and raised their price target for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $56.00 price objective on shares of Tempus AI in a research note on Tuesday, January 14th. Loop Capital cut their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research report on Tuesday, January 14th. Finally, Piper Sandler restated a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $56.36.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.